Stocks To Watch on Analyst Actions: Revance Therapeutics Inc. (NASDAQ:RVNC), Brandywine Realty Trust (NYSE:BDN), Sodastream International Ltd. (NASDAQ:SODA)

Analysts at Janney Capital Markets have lowered their 2014 and 2015 earnings estimates for Chiquita Brands International Inc. (NYSE:CQB), while maintaining a neutral rating on the stock. The firm has lowered its 2014 EPS to $1.01 from $1.12, and reduced its 2015 EPS forecast to $1.25 from $1.29 a share. The estimate adjustment comes just a few days after Chiquita Brands International Inc. (NYSE:CQB) reported Q4 2013 … Continue reading Stocks To Watch on Analyst Actions: Revance Therapeutics Inc. (NASDAQ:RVNC), Brandywine Realty Trust (NYSE:BDN), Sodastream International Ltd. (NASDAQ:SODA)

Trending Stocks : Toyota Motor Corporation (NYSE:TM), DIRECTV (NASDAQ:DTV), KCG Holdings, Inc. (NYSE:KCG), Seabridge Gold, Inc. (NYSE:SA), Revance Therapeutics, Inc. (NASDAQ:RVNC),

Toyota Motor Corp (NYSE:TM)‘s stock had its “neutral” rating reiterated by Zacks in a research report issued to clients and investors on Thursday. They currently have a $123.00 price target on the stock. Zacks‘s price target would indicate a potential upside of 2.99% from the company’s current price. Toyota Motor Corporation (NYSE:TM) belongs to Consumer Goods sector. Its net profit margin is 7.40% and weekly … Continue reading Trending Stocks : Toyota Motor Corporation (NYSE:TM), DIRECTV (NASDAQ:DTV), KCG Holdings, Inc. (NYSE:KCG), Seabridge Gold, Inc. (NYSE:SA), Revance Therapeutics, Inc. (NASDAQ:RVNC),

Unusual Volume at bioetch stocks: CASI Pharmaceuticals (NASDAQ:CASI), Codexis (NASDAQ:CDXS), China Biologic Products (NASDAQ:CBPO), Revance Therapeutics (NASDAQ:RVNC), Oncolytics Biotech, (NASDAQ:ONCY)

CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer and other diseases, announced today that its orally-active, Aurora A/angiogenic kinase inhibitor, ENMD-2076, has received Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of hepatocellular carcinoma (HCC). CASI Pharmaceuticals Inc (NASDAQ:CASI) stock performance was -4.79% in last session and finished the day at $1.85. … Continue reading Unusual Volume at bioetch stocks: CASI Pharmaceuticals (NASDAQ:CASI), Codexis (NASDAQ:CDXS), China Biologic Products (NASDAQ:CBPO), Revance Therapeutics (NASDAQ:RVNC), Oncolytics Biotech, (NASDAQ:ONCY)